HCP Live

Weekly Recap

NeurologyLive Weekly Recap

Each week on Saturday morning, the NeurologyLive^® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.

MS Treatments Linked With PML, Neflamapimod Effectiveness Based on P-Tau181 Levels, Nerivio Safe in Pregnant Women

MS Treatments Linked With PML, Neflamapimod Effectiveness Based on P-Tau181 Levels, Nerivio Safe in Pregnant Women

NeurologyLive® Staff

September 16th 2023

Neurology News Network for the week ending September 16, 2023. [WATCH TIME: 3 minutes]

CNM-Au8 Improves Survival in ALS, New Parkinson Risk Factor Identified, Pamrevlumab Falls Short in Phase 3 Study

CNM-Au8 Improves Survival in ALS, New Parkinson Risk Factor Identified, Pamrevlumab Falls Short in Phase 3 Study

NeurologyLive® Staff

September 9th 2023

Neurology News Network for the week ending September 9, 2023. [WATCH TIME: 3 minutes]

Cell Therapy Bemdaneprocel Meets Primary Objective, Retinal Thickness in Parkinson Disease, TERIS Study Findings Published

Cell Therapy Bemdaneprocel Meets Primary Objective, Retinal Thickness in Parkinson Disease, TERIS Study Findings Published

NeurologyLive® Staff

September 2nd 2023

Neurology News Network for the week ending September 2, 2023. [WATCH TIME: 3 minutes]

DT-216 Reduces Frataxin Levels in FA, Valbenazine FDA-Approved for Huntington Chorea, EU Approves Atogepant as Migraine Preventive

DT-216 Reduces Frataxin Levels in FA, Valbenazine FDA-Approved for Huntington Chorea, EU Approves Atogepant as Migraine Preventive

NeurologyLive® Staff

August 26th 2023

Neurology News Network for the week ending August 26, 2023. [WATCH TIME: 3 minutes]

FDA Approves DaxibotulinumtoxinA for Cervical Dystonia, Genetic Parkinson Trial Announced, DBS Improves Poststroke Mobility

FDA Approves DaxibotulinumtoxinA for Cervical Dystonia, Genetic Parkinson Trial Announced, DBS Improves Poststroke Mobility

NeurologyLive® Staff

August 19th 2023

Neurology News Network for the week ending August 19, 2023. [WATCH TIME: 4 minutes]

Vyvgart Hytrulo Meets Primary End Point, Trial on Fibromyalgia-Type Long COVID Continues, Aspirin Increased Intracranial Bleeding in Elders

Vyvgart Hytrulo Meets Primary End Point, Trial on Fibromyalgia-Type Long COVID Continues, Aspirin Increased Intracranial Bleeding in Elders

NeurologyLive® Staff

August 12th 2023

Neurology News Network for the week ending August 12, 2023. [WATCH TIME: 3 minutes]

MS Medications Added to WHO Essential List, Epigenome Therapy Shows Efficacy in AD, Phase 3 NEURO-TTransform Results Announced

MS Medications Added to WHO Essential List, Epigenome Therapy Shows Efficacy in AD, Phase 3 NEURO-TTransform Results Announced

NeurologyLive® Staff

August 5th 2023

Neurology News Network for the week ending August 5, 2023. [WATCH TIME: 4 minutes]

Positive Data on Dravet Therapy STK-001, FDA Clears Zoom 88 LDP Support, MS Diagnostic Guidelines Updated

Positive Data on Dravet Therapy STK-001, FDA Clears Zoom 88 LDP Support, MS Diagnostic Guidelines Updated

NeurologyLive® Staff

Neurology News Network for the week ending July 29, 2023. [WATCH TIME: 4 minutes]

TRAILBLAZER-ALZ-2 Data of Donanemab Published, Risdiplam Effective in SMA up to 4 Years, Preclinical Alzheimer Study of Lecanemab Announced

TRAILBLAZER-ALZ-2 Data of Donanemab Published, Risdiplam Effective in SMA up to 4 Years, Preclinical Alzheimer Study of Lecanemab Announced

NeurologyLive® Staff

Neurology News Network for the week ending July 22, 2023. [WATCH TIME: 3 minutes]

Sleeping Pills and Increased Mortality, IPX203 Receives CRL, CT1812 Impacts Brain Function

Sleeping Pills and Increased Mortality, IPX203 Receives CRL, CT1812 Impacts Brain Function

NeurologyLive® Staff

Neurology News Network for the week ending July 8, 2023. [WATCH TIME: 3 minutes]

Gene Therapy AMT-130 in Huntington Disease, NDA Submitted for Troriluzole in Spinocerebellar Ataxia, FDA Clears Alzheimer Assays

Gene Therapy AMT-130 in Huntington Disease, NDA Submitted for Troriluzole in Spinocerebellar Ataxia, FDA Clears Alzheimer Assays

NeurologyLive® Staff

Neurology News Network for the week ending July 1, 2023. [WATCH TIME: 3 minutes]

CNM-Au8 Reduces Neurofilament Light, Candesartan Benefits Headache, Ketamine Shows Potential in Migraine

CNM-Au8 Reduces Neurofilament Light, Candesartan Benefits Headache, Ketamine Shows Potential in Migraine

NeurologyLive® Staff

Neurology News Network for the week ending June 24, 2023. [WATCH TIME: 3 minutes]

Phase 3 LAVENDER Trial Results Published, Protective and Risk Factors of Insomnia, Lecanemab Gets Positive FDA AdComm Review

Phase 3 LAVENDER Trial Results Published, Protective and Risk Factors of Insomnia, Lecanemab Gets Positive FDA AdComm Review

NeurologyLive® Staff

Neurology News Network for the week ending June 17, 2023. [WATCH TIME: 3 minutes]

BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS

BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS

NeurologyLive® Staff

Neurology News Network for the week ending June 10, 2023. [WATCH TIME: 3 minutes]

CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule

CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule

NeurologyLive® Staff

Neurology News Network for the week ending June 2, 2023. [WATCH TIME: 3 minutes]

Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation

Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation

NeurologyLive® Staff

Neurology News Network for the week ending May 27, 2023. [WATCH TIME: 3 minutes]

Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD

Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD

NeurologyLive® Staff

Neurology News Network for the week ending May 20, 2023. [WATCH TIME: 4 minutes]

CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset

CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset

NeurologyLive® Staff

Neurology News Network for the week ending May 13, 2023. [WATCH TIME: 4 minutes]

Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition

Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition

NeurologyLive® Staff

Neurology News Network for the week ending May 6, 2023. [WATCH TIME: 4 minutes]

Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups

Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups

NeurologyLive® Staff

April 30th 2023

Neurology News Network for the week ending April 30, 2023. [WATCH TIME: 4 minutes]

DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy

DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy

NeurologyLive® Staff

April 22nd 2023

Neurology News Network for the week ending April 22, 2023. [WATCH TIME: 4 minutes]

EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward

EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward

NeurologyLive® Staff

April 15th 2023

Neurology News Network for the week ending April 15, 2023. [WATCH TIME: 4 minutes]

Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA

Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA

NeurologyLive® Staff

Neurology News Network for the week ending April 8, 2023. [WATCH TIME: 4 minutes]

Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms

Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms

NeurologyLive® Staff

Neurology News Network for the week ending April 1, 2023. [WATCH TIME: 4 minutes]

Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea

Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea

March 25th 2023

Neurology News Network for the week ending March 25, 2023. [WATCH TIME: 3 minutes]

Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline

Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline

NeurologyLive® Staff

March 18th 2023

Neurology News Network for the week ending March 18, 2023. [WATCH TIME: 4 minutes]

Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching

Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching

NeurologyLive® Staff

March 11th 2023

Neurology News Network for the week ending March 11, 2023. [WATCH TIME: 3 minutes]

Gene Therapy ST-920 Shows Benefit in Fabry, Intermittent Calorie Restriction in Multiple Sclerosis, High Economic Burden Identified in NMOSD

Gene Therapy ST-920 Shows Benefit in Fabry, Intermittent Calorie Restriction in Multiple Sclerosis, High Economic Burden Identified in NMOSD

NeurologyLive® Staff

Neurology News Network for the week ending March 4, 2023. [WATCH TIME: 3 minutes]

Sodium Oxybate Alters Sleep Structure, FDA Approves Deutetrabenazine, Associations of Stroke Decreased With Age

Sodium Oxybate Alters Sleep Structure, FDA Approves Deutetrabenazine, Associations of Stroke Decreased With Age

NeurologyLive® Staff

February 25th 2023

Neurology News Network for the week ending February 26, 2022. [WATCH TIME: 3 minutes]

CNM-Au8 Impacts Neuronal Structural Integrity, Mobile Stroke Units and Direct Transfer to Angiography, Cognitive Impairments Higher in RBD Before Parkinson Disease

CNM-Au8 Impacts Neuronal Structural Integrity, Mobile Stroke Units and Direct Transfer to Angiography, Cognitive Impairments Higher in RBD Before Parkinson Disease

NeurologyLive® Staff

February 18th 2023

Neurology News Network for the week ending February 18, 2023. [WATCH TIME: 4 minutes]

1 2 3 4 5 6 7 8 >

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.